# CALGB 140503 (NCT00499330)

> Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: stage IA non-small cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00499330
- Phase: not given
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Lung Cancer
- Interventions: lobectomy; segmentectomy or wedge resection
- Primary outcome: disease-free survival

## Some of the questions raised in the 40 most recent indexed sources

_Automated from the 40 newest of 81 indexed sources (Feb 2023 – Oct 2026). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice._

- Whether wedge resection and segmentectomy perform alike within the sublobar arm, and which segments were resected
- Whether a fuller lymph node dissection is needed after negative intraoperative frozen-section nodal sampling
- Whether tumors upstaged for visceral pleural invasion call for adjuvant systemic therapy trials rather than a larger resection
- How second primary lung cancers after lobar versus sublobar resection should weigh on preserving lung tissue

## Indexed commentary on CALGB 140503 so far

Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 79 posts on X
- 2 YouTube videos

## Order

Deep, $1,950 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=calgb-140503-nct00499330

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00499330", "email": "<work email>"}; the inbox owner confirms by the emailed link.
